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Antifungal drug resistanceAbstract The importance of dental plaque bioﬁlms for oral and dental disease was proposed
recently. This study determined the presence of Candida spp. in dental plaques of both males
and females. Pooled samples of dental plaque were collected from 25 males and 55 females aged
between 25 and 50 years. Colony growth was veriﬁed and 30 Candida isolates were chosen for
the screening. The identiﬁcation of bioﬁlm forming Candida was conﬁrmed by performing several
screening techniques (Microtiter plate method, Test tube method). Screened positive Candida iso-
lates DV1, DV17 and DV21 were characterized by several biochemical tests including growth on
Hi-Crome agar. Molecular characterization has also been performed for isolates DV1, DV17 and
DV21 by sequencing 18S rRNA gene. Phylogenetic trees were constructed for three Candida isolates
and identiﬁed as Candida albicans DV1, C. albicans DV17 and C. albicans DV21. The bioﬁlm for-
mation of Candida spp. on catheter was evaluated using scanning electron microscopic analysis. The
extra cellular polysaccharide (EPS) quantity was measured with the effect of different carbon
sources, adherence time and bioﬁlm forming time. The above isolates were screened for antifungal
resistance against six clinically important antifungal agents such as Amphotericin B, Ketaconazole,
Fluconazole, Itraconazole, Nystatin and Clotrimazole (10 lg/ml). The bioﬁlm forming isolates were
Table 1 Classiﬁcation of Candida
method.
Mean OD values Adherence
>0.320 Strong
0.120–0.320 Moderately
<0.120 Non
56 D. Dhanasekaran et al.signiﬁcantly resistant to the antifungal drugs in comparison with non-bioﬁlm forming Candida iso-
lates. The present study reveals the presence of Candida bioﬁlm on human dental surface and indi-
cates the magnitude of antibiotic resistance.
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Generally microbes attach to the surface and produce extracel-
lular polysaccharides, resulting in the formation of a bioﬁlm.
The bioﬁlm mode of growth is beneﬁcial for microorganisms
as it provides a higher degree of stability compared to a plank-
tonic existence and organisms within a bioﬁlm are more resis-
tant to environmental challenges, such as low nutrient
availability, high ﬂuid shear, antibiotic and antimicrobial
agents.6
Although bacterial bioﬁlms have been the focus of many
studies, detailed investigations into the biology and pathogen-
esis of fungal bioﬁlms have been initiated recently.4,5 Candida
species are normal commensals of humans, which facilitates
their encounter with most implanted biomaterials.
Candida species are now the fourth most common cause of
nosocomial BSIs worldwide.15 Candida infections are difﬁcult
to manage due to their persistent nature and associated drug
resistance. Candida is the major fungal pathogen of humans
causing a variety of afﬂictions ranging from superﬁcial muco-
sal diseases to deep seated mycoses.
Bioﬁlm formation is a major virulence factor in the path-
ogenicity of Candida and Candida bioﬁlms are difﬁcult toadherence by the MTP
Bioﬁlm formation
High
Moderate
Non/weak
Plate 1 Dental seradicate especially because of their very high antifungal
resistance. Consequently, research into the pathogenicity of
Candida has focused on the prevention and management of
bioﬁlm development, their architecture, and antifungal
resistance.13
Candida is frequently isolated from the human mouth, yet
few carriers develop clinical signs of candidiasis. Oral candidi-
asis presents clinically in many forms. This reﬂects the ability
of the yeast to colonize different oral surfaces and the variety
of factors which predispose the host to Candida colonization
and subsequent infection. Colonization of the oral cavity ap-
pears to be facilitated by several speciﬁc adherence interactions
between Candida and oral surfaces which enable the yeast to
resist host clearance mechanisms. Thus, Candida has been
shown to adhere to complement receptors, various extracellu-
lar matrix proteins and speciﬁc sugar residues displayed on
host or bacterial surfaces in the oral cavity.
Although there are many reports on the phenomenon of
incomplete penetration of antimicrobial agents through bacte-
rial bioﬁlms, there is no detailed investigation on Candida bio-
ﬁlms from human dental surface. Therefore, the present study
was planned to deal with Candida bioﬁlms isolated from dental
plaque and further characterize the bioﬁlm forming Candida
spp.
2. Materials and methods
2.1. Sample collection
A total of 80 samples (dental swabs) were collected from the
candidates in and around Tiruchirappalli District. The dental
swabs were collected from the individuals who have notwab collection.
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transferred to sterile test tubes and brought to the laboratory
for further investigation.
2.2. Isolation of Candida spp.
The collected dental swabs were inoculated on sterilized Sab-
ouraud’s dextrose agar (SDA) medium and incubated at
37 C for 24 h. After incubation, the presence of Candida col-Table 2 Distribution of bioﬁlm forming Candida spp.
Total No. of dental swabs collected (n= 80) Sele
Male Female Mal
25 (31.35%) 55 (68.75%) 9 (3
Table 3 Screening of Candida isolates for bioﬁlm formation.
S. No Name of the Candida isolates Qualitati
1. DV1 +++
2. DV2 +++
3. DV3 ++
4. DV4 ++
5. DV5 ++
6. DV6 ++
7. DV7 ++
8. DV8 +
9. DV9 ++
10. DV10 ++
11. DV11 ++
12. DV12 ++
13. DV13 ++
14. DV14 ++
15. DV15 ++
16. DV16 ++
17. DV17 +++
18. DV18 +
19. DV19 ++
20. DV20 ++
21. DV21 +++
22. DV22 ++
23. DV23 ++
24. DV24 ++
25. DV25 ++
26. DV26 +++
27. DV27 +++
28. DV28 ++
29. DV29 ++
30. DV30 +++
Table 4 Screening of Candida isolates for the detection of bioﬁlm f
No. of isolates Bioﬁlm formation
Candida isolates (n= 30) High/strong
Moderate
Weak/non
MTP – Microtitre plate method, TM – Tube method.onies was recorded. Candida isolates obtained above were
tested for their bioﬁlm forming ability at different time inter-
vals (24, 48, and 72 h). The isolates were maintained in SDA
agar slants at 20 C and subcultured monthly.
2.3. Detection of bioﬁlm forming Candida spp.
Bioﬁlm production was estimated qualitatively for all the 30
Candida isolates by microtitre plate method and tube method11ction of Candida isolates from the dental swabs (n= 30)
e Female
6.00%) 21 (38.18%)
ve assay TM Quantitative assay MTP (OD at 492 nm)
0.350
0.213
0.116
0.109
0.197
0.118
0.054
0.297
0.062
0.043
0.095
0.290
0.152
0.187
0.131
0.259
0.342
0.057
0.125
0.135
0.338
0.096
0.148
0.091
0.219
0.335
0.340
0.185
0.238
0.200
ormation.
Screening methods
MTP (%) TM (%)
5 (16.66) 7 (23.33)
15 (50.00) 21 (70.00)
10 (33.33) 2 (6.66)
Figure 1 Total Candida population in 1 cm2 area of catheter.
Microtitre plate with Candida growth
Microtitre plate containing Candida growth stained with 0.1% CV 
Biofilm formation on glass surfaces at liquid-air interface under static growth conditions 
Plate 2 Screening of bioﬁlm forming Candida spp. by the microtitre plate method and the tube method.
58 D. Dhanasekaran et al.as described previously. All tests were carried out in duplicate
and the results were averaged. In the present study, only
strongly adherent ones were taken as bioﬁlm positive while
weakly adherent ones were taken as negative for bioﬁlm
production.2.4. Tube method (TM)
A qualitative assessment of bioﬁlm formation was determined
by following the method of Millsap et al.12 SDB (10 ml) was
inoculated with loopful of Candida from overnight culture
00.2
0.4
0.6
0.8
1
1.2
1.4
O
D
 (
49
2 
n
m
)
DV1 DV17 DV21 DV26 DV27
Name of the isolates
Glucose
Dextrose
Sucrose
Galactose
Figure 2 Effect of carbon sources on Candida bioﬁlm formation.
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anted and washed with phosphate buffered saline (PBS, pH
7.3) and dried. Dried tubes were stained with crystal violet
(0.1%). Excess stain was removed and tubes were washed with
deionized water. Tubes were then dried in inverted position
and observed for bioﬁlm formation.
Bioﬁlm formation was considered positive when a visible
ﬁlm was lined on the wall and bottom of the tube. Ring forma-
tion at the liquid interface was not indicative of bioﬁlm forma-
tion. Tubes were examined and the amount of bioﬁlm
formation was scored as follows (+) as weak/non (++) as
moderate and (+++) as strong.
2.5. Microtitre plate method (MTP)
The microtitre plate assay described by Millsap et al.12 is the
most widely used method and was considered as standard test
for the detection of bioﬁlm formation. In the present study, 30
Candida isolates were screened for their ability to form bioﬁlm.
Individual wells of sterile, polystyrene, 96 well-ﬂat bottom
microtitre plates (Tarson, Kolkata, India) were ﬁlled with
100 ll aliquots of the cell suspension and only broth served
as control to check sterility and non-speciﬁc binding of media.
The microtitre plates were incubated for 72 h at 37 C. After
incubation content of each well was gently removed by tappingFigure 3 Agarose gel electrophoresis (0.8%) of chromosomal
DNA of Candida spp.the plates. The wells were washed four times with 200 ll of
PBS (pH 7.2) to remove free-ﬂoating ‘planktonic’ organism.
Bioﬁlms formed by adherent ‘sessile’ organisms in plate were
stained with crystal violet (0.1% w/v). Excess stain was rinsed
off by thorough washing with deionized water and plates were
kept for drying. Adherent Candida cells usually formed a bio-
ﬁlm at the bottom of the wells and were uniformly stained with
crystal violet. Optical density (OD) of stained adherent Can-
dida bioﬁlm was determined with a micro ELISA auto reader
(Model 680, Bio Rad) at wavelength of 492 nm. These OD val-
ues were considered as an index of Candida adhering to surface
and forming bioﬁlms (Table 1).
2.6. Characterization and identiﬁcation of Candida spp.
2.6.1. Cultural characterization
The Candida isolates were inoculated on sabouraud dextrose
agar and incubated at 37 C for 24–48 h. Colony morphologyLane 1 (L1):  Molecular Marker 
Lane 2 (L2):  Amplified product of DV1 
Lane 3 (L3): Amplified product of DV17 
Lane 4 (L4): Amplified product of DV21 
Lane 5 (L5): Amplified product of DV26 
Lane 6 (L6): Amplified product of DV27 
Figure 4 Agarose gel electrophoresis (1.2%) of ampliﬁed 18S
rRNA of Candida spp.
Figure 5 Phylogenetic tree plotted from 18S rRNA gene sequence of Candida albicans DV1 isolate.
Figure 6 Phylogenetic tree plotted from 18S rRNA gene sequence of the Candida albicans DV17 isolate.
60 D. Dhanasekaran et al.was recorded with different arrangement of colony, size and
margin for different species on the SDA.
2.6.2. Microscopic characterization
2.6.2.1. LCB mount. Clean glass slide was taken and one drop
of lacto phenol dye was placed on it. Then a loopful of culture
was mixed to the dye and a sterile cover slip was placed overthe dye without any air bubbles. Then, the slide was observed
under the light microscope and the results were recorded.
2.6.2.2. Germ tube test. Serum was separated from human
blood by centrifugation at 10,000 rpm for 10 min at 4 C.
Two milliliters of serum was taken in an eppendorf tube. Can-
dida culture was inoculated into the serum and incubated at
Human dental bioﬁlm: Screening, characterization, in vitro bioﬁlm formation 6137 C for 2–4 h. After incubation, one drop of serum was
placed on the clean glass slide and a clean cover slip was placed
over the drop without any air bubbles. Then the slide was ob-
served under the microscope and results were recorded.
2.6.3. Biochemical characterization
2.6.3.1. Nitrate reduction and urease test. The Candida cultures
were inoculated on nitrate broth and christensen’s urea agar
slants. Then the tubes were incubated at 37 C for 24–48 h.
After incubation, few drops of alpha naphthalamine and sulfa-
nilic acid were added to the nitrate broth. The tubes were ob-
served for a change of color and the results were recorded. The
formation of a red color indicates positive reaction of nitrate
reduction and a change of color from yellow to pink indicates
positive for the urease test.
2.6.3.2. Growth on Hichrom Candida agar medium. Hichrom
Candida agar is increasingly being reported as a medium used
to differentiate Candida albicans from non – albicans Candida
(NAC) species. Thus, the selected bioﬁlm forming Candida
isolates were inoculated onto Hichrom Candida agar medium
(Hi-Media, India) and incubated at 37 C for 24–48 h. Color
indication was observed and recorded.
2.6.4. Molecular characterization of Candida spp.
2.6.4.1. Isolation of genomic DNA. Bioﬁlm forming Candida
isolates were transferred to ﬂasks containing 50 ml of SDB
and incubated at 37 C for 24 h. Then, the culture pellet was
obtained by centrifugation at 10,000 rpm for 10 min at 4 C.Figure 7 Phylogenetic tree plotted from 18S rRNA gTwo milliliters of the culture pellet was taken and washed twice
with 400 ll solution I and resuspended with the same solution.
After vortexing, 50 ll of 10% SDS was added, mixed by
inverting the tube and incubated at 55 C for 30 min. Then
50 ll of protinease K was added and incubated for 1 h at
37 C. After that 500 ll of phenol:chloroform was added and
vortexed brieﬂy. The mixture was centrifuged at 8000 rpm
for 8 min. Phenol:chloroform step was carried out again with
the aqueous phase. Then to the aqueous phase 500 ll of chlo-
roform was added and centrifuged at 8000 rpm for 8 min. The
aqueous phase was taken, to that 25 ll of 5 M NaCl and 1 ml
of 99.99% chilled ethanol was added and incubated for over-
night at 20 C. Then the mixture was centrifuged at
13,000 rpm for 30 min at 4 C. Pellet was taken and 1 ml of
70% ethanol was added and centrifuged at 13,000 rpm for
15 min at 4 C. The above step was repeated again and the pel-
let was air dried and mixed with 50 ll of TE buffer and stored
at 20 C for further analysis. The quality of the extracted
DNA was veriﬁed by gel electrophoresis in 0.8% (w/v) agarose
containing 0.5 mg ml1 of ethidium bromide and viewed using
UVP (UK) gel documentation system.
2.7. Ampliﬁcation and sequencing of 18S rRNA from Candida
spp.
The extracted genomic DNA of the Candida isolates DV1,
DV17 and DV21 was ampliﬁed by using speciﬁc forward and
reverse primers namely 50-CATCCATTTTCAGGGCTAGT-
30 and 30-CGCTGAACTTAAGCATATCA-50. The fragmentene sequence of the Candida albicans DV21 isolate.
62 D. Dhanasekaran et al.ampliﬁcation was carried out in Eppendorf master cycler (Ger-
many) with the following temperature proﬁle of initial dena-
turation (94 C for 5 min) followed by denaturation (94 C
for 45 s), annealing at (59 C for 45 s), extension (72 C for
1 min) and a ﬁnal extension (72 C for 7 min). The ampliﬁed
product was analyzed electrophoretically in 1.2% of agarose
gel containing ethidium bromide (0.5 mg ml1) and viewed
using UVP (UK) gel documentation system. The amplicons
were then puriﬁed and subjected for sequencing at MWG Bio-
tech. Pvt. Ltd (Bangalore).
2.8. Phylogenetic analysis
The nucleotide sequences were obtained from sequencing the
PCR products. A BLAST of obtained sequences were per-
formed with that of available EMBL database using the site
http://www.ncbi.nlm.nih.gov/genebank and the sequences
were subjected to phylogenetic analysis using bioinformatics
tool available in online Mega IV and Clustal W.Figure 8 Secondary structure of 18S r2.9. Prediction of 18S rRNA secondary structure
The secondary structure of the 18S rRNA was predicted using
the bioinformatics tool available in online www.gene-
bee.msu.su/services/rna 2-reduced.html.
2.10. Analysis of restriction sites in 18S rRNA
The restriction sites present on the bioﬁlm forming Candida
spp.18S rRNA were analyzed using the NEB Cutter program
version 2.0 tool in online http://tools.neb.com/NEBCutter2/
index.php.
2.11. Bioﬁlm formation by Candida spp. on catheter
Bioﬁlms of Candida were grown on small sterile catheter piece
(surface area 1.0 cm2) cut from Foley catheter (Siliconised) ob-
tained from JIPMER, manufactured by SISCO latex Pvt. Ltd.,
(Puducherry). The material was sterilized with ethanol (70%)RNA of the Candida albicans DV1.
Figure 9 Secondary structure of 18S rRNA of the Candida albicans DV17.
Figure 10 Secondary structure of 18S rRNA of the Candida albicans DV21.
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Figure 11 Restriction site analysis of 18S rRNA of Candida albicans DV1.
64 D. Dhanasekaran et al.and rinsed with distilled water. Flat square pieces, 1.0 cm in
diameter, were obtained by cutting with a sterile surgical knife,
the protocol followed by Chandra et al.2 A 100 ll quantity of
the cell suspension was applied to the surfaces of 1.0 cm2 cath-
eter piece placed in a sterile petri plate. The cells were allowed
to adhere for 90 min at 37 C (adhesion phase). Non adherent
cells were removed from the tube by gently washed with 5 ml
of PBS. Tubes were then submerged in 4 ml of SDB containing
the appropriate carbohydrate supplement. Tube in which no
cells were added serves as the negative control. Control and
experimental tubes were incubated at 37 C for speciﬁed time
periods (bioﬁlm growth phase).2.12. Microscopic evaluation of Candida bioﬁlms on catheter by
SEM
Candida bioﬁlm formed after 72 h incubation on catheter piece
from each isolate was observed under SEM. Catheter pieces
were picked up by sterile forceps from the SDB and gently
washed in 5 ml of PBS to remove non adherent cells. The
pieces were then placed in a sterilized petri plate. The bioﬁlms
were air dried for 3 h. The pieces were then coated with gold
and then imaged using a SEM in a high vacuum mode at
10 kV. Scanning electron micrographs of the bioﬁlm were ta-
ken at 1000–3000· magniﬁcation.2.12.1. Optimization of Candida bioﬁlm formation
2.12.1.1. Effect of adherence time. Catheter was cut into small
pieces with a sterile knife (1 cm2 surface area) and sterilized
with 70% ethanol. Candida isolates were inoculated into the
sterile sabouraud dextrose broth containing sterile catheter
pieces and incubated at 37 C for different adhesion times
(30, 90 and 180 min) for bioﬁlm growth. The bioﬁlm growth
was determined by OD measurements at 492 nm.
2.12.1.2. Effect of incubation time. Sabouraud dextrose broth
was prepared and sterilized. Catheter was cut into small pieces
with a sterile knife (1 cm2 surface area) and sterilized with 70%
ethanol. Candida isolates were inoculated into the sterile sab-
ouraud dextrose broth containing sterile catheter pieces and
incubated at 37 C for different bioﬁlm formation times (24,
48 and 72 h). The bioﬁlm growth was determined by OD mea-
surements at 492 nm.
2.12.1.3. Total Candida population in 1 cm2 area of catheter.
The number of colonies present in 1 cm2 of area in the catheter
piece was estimated. About 0.1 ml of Candida cultures was
inoculated into test tubes containing 10 ml of SD broth. The
sterilized catheter piece was immersed in the broth and was
incubated at 37 C for 24–48 h. Then about 1 cm2 area of bio-
ﬁlm was scrapped and serially diluted in distilled water and re-
plated in the SDA.
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formula,
C.F.U/ml of catheter piece = Number of Colonies/Volume
of the suspension · Dilution Factor.
2.12.1.4. Effect of carbon sources on Candida bioﬁlm formation.
Sabouraud dextrose broth was modiﬁed with different sugars
such as glucose, sucrose and galactose. The Candida isolates
were inoculated in sterile modiﬁed SD broth, and incubated
at 37 C for 24 h. Increase in bioﬁlm formation in the presence
of different carbon sources was determined by OD
measurements.
2.12.1.5. Isolation of EPS. EPS was isolated from the culture
supernatants by precipitation with acetone. SDB were inocu-
lated with overnight yeast cultures and incubated at 37 C
for 24 h in an orbital shaker. Yeasts were removed by centrifu-
gation and culture supernatant was added to 1.5 volumes of
cold acetone containing 1 g of sodium acetate to aid precipita-
tion. After 2 h at 4 C, the resultant precipitate was collected
by centrifugation at 1300 rpm for 30 min. The pellet was re-
dissolved in a small volume of distilled water and the insoluble
material was removed by centrifugation. Water soluble poly-
mer was recovered from precipitation and evaporated to dry-
ness in vacuo. The dried material was weighed and the yield
was calculated as a percentage of the combined dry weight
of yeast cells and EPS.Figure 12 Restriction site analysis of 182.12.1.6. Antifungal resistance of bioﬁlm forming Candida spp..
DV1, DV17 and DV21 Candida isolates were tested for their
susceptibility to various ﬁrst line antibiotics such as Amphoter-
icin B, Ketaconazole, Fluconazole, Itraconazole, Nystatin and
Clotrimazole by the Kirby–Bauer disc diffusion method.
2.12.1.7. Kirby–Bauer disc diffusion method. The bioﬁlm form-
ing Candida isolates DV1, DV17 and DV21 were inoculated
into the sterile SDB and incubated at 37 C for 24 h. After
incubation, a lawn of Candida isolates was made on SDA
plates by using a sterile cotton swab. Then antibiotic discs were
placed on each plate using the dispenser and gently pressed
onto the surface of the agar with a sterile stick to assure good
contact. The plates were incubated at 37 C for 24 h. After
incubation each plate was examined for the presence of zones
of inhibition around the antibiotic disc. The diameter of the
inhibition zone was measured and compared with the standard
interpretative chart to determine whether the organism is sen-
sitive or resistant to the antibiotic.
2.12.1.8. MIC by agar dilution method. Candida bioﬁlm isolates
were conﬁrmed as antifungal resistance by antibiotic agar dilu-
tion using MHA. MICs for different antifungal agents were
determined by agar dilution, as recommended by CLSI. Anti-
biotics were tested at concentrations of 10–64 lg/ml and MICs
were read manually after 24 h of incubation. Control was per-
formed by using non bioﬁlm former strains. The strains withS rRNA of Candida albicans DV17.
66 D. Dhanasekaran et al.minimum inhibitory concentration (MIC) of 610, P10 and
P16 lg/ml were taken as susceptible, intermediate and resis-
tant, respectively. Isolates exhibiting an MIC of 16–32 lg/ml
were considered to be of borderline resistance.
3. Results and discussion
3.1. Isolation of Candida spp.
The mouth is a unique part of the body in that it contains ex-
posed mineralized tissues, in the form of teeth. Beads of crys-
talline hydroxyapatite (HA) have been used in adhesion assays
as a model for studying microbial adhesion to dental surfaces.
First report of bioﬁlm formation on oral cavities was done by
Odds13 who isolated C. albicans from the oral candidiasis.
Samaranayake and MacFarlane19 reported that non albicans
Candida also form bioﬁlm on the oral candidasis. Ramage
et al.16 isolated Candida dubliniensis from the oropharyngeal
sample. The present investigation on the isolation of bioﬁlm
forming Candida spp. from dental surfaces was different from
the previous ﬁndings.
In the present study, a total of 80 dental swabs collected
(Plate 1) from different individuals (68.75% females and
31.35% males) were used for the screening of bioﬁlm produc-
ing Candida. Among 80 individuals dental swabs, only 30
showed positive results for the Candida spp. The maximumFigure 13 Restriction site analysis of 1positive individuals for oral Candida were females (38.18%)
when compared with males (36.00%) (Table 2). All the 30
Candida isolates showed structurally distinct morphology on
SDA which were used for bioﬁlm analysis and antifungal
resistance.
3.2. Detection of bioﬁlm forming Candida spp.
A total 30 Candida isolates were screened for bioﬁlm forma-
tion by MTP and TM assays. In the standard MTP assay,
from the total number of 30 isolates tested for bioﬁlm forma-
tion (Tables 3 and 4), strong bioﬁlm producers were 5
(16.66%), 15 (50.00%) were moderate and 10 (33.33%) iso-
lates were considered as non or weak bioﬁlm producers (Ta-
ble 4; Plate 2). The ﬁve strong bioﬁlm producers showed
signiﬁcant optical density values of more than 0.330 in micro-
titre plate assay. Similar results were obtained by Dhanaseka-
ran et al.3 for the isolate Bacillus sp. DR4. It showed maximum
biofouling activity in the microtiter plate assay with a signiﬁ-
cant optical density of 0.596.
The tube method showed good correlation with the MTP
assay for strongly bioﬁlm forming isolates and a total of 7
(23.33%) isolates were picked up as strong and 21 (70%) were
moderate bioﬁlm producers (Tables 3 and 4). However, it was
difﬁcult to discriminate between moderate and weak bioﬁlm
producing isolates (Plate 2). From the bioﬁlm screening assays8S rRNA of Candida albicans DV21.
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DV27 were selected for further investigation.
3.3. Characterization and identiﬁcation of Candida spp.
All the 30 Candida isolates were found to have bioﬁlm activity.
Among them ﬁve signiﬁcant bioﬁlm forming Candida isolates
were justiﬁably chosen for morphological, biochemical, molec-
ular characterization and identiﬁcation.
3.3.1. Cultural characterization
Cultural characteristics of the Candida spp. such as the
arrangement of colony, size, shape and margin were studied
on SDA. It was observed that all the bioﬁlm forming Candida
isolates showed distinct shape and an elevated margin.
3.3.2. Microscopic characterization
In the LCB mount, all the Candida isolates appeared as bud-
ding yeast cells and a few of them showed the presence of
pseudohyphae. In the germ tube test, many of isolates showed
as germ tube positive but a few isolates did not produce the
germ tube.
3.3.3. Biochemical characterization
The bioﬁlm forming Candida isolates were evaluated for bio-
chemical tests such as nitrate reduction and the urease test.
All isolates showed a positive result for the nitrate reduction
test which is indicated by the formation of red color. All the
isolates were negative for the urease test which is conﬁrmedCandida sp. DV1
Candida sp
Plate 3 Candida spp. bioﬁlm growby the absence of pink color in christensen’s urea agar
slants.
3.3.4. Growth on Hichrom Candida agar medium
In the present study the bioﬁlm forming Candida isolates dif-
fered in their colony color on Hichrom agar medium. The Can-
dida isolates DV1, DV17, DV21 and DV26 produced a green
color and the isolate DV27 alone produced a white color on
Hichrom agar medium.
3.3.5. Molecular characterization
The bioﬁlm forming isolates were identiﬁed and characterized
using different parameters such as morphological, biochemical
and cultural characters. The morphological and biochemical
characters of the isolates showed similarity to the Candida
spp. The identiﬁcation of the isolates based on morphology
and biochemical characteristics may vary due to various fac-
tors. Thus, the molecular characterization gives the standard
tool for identiﬁcation of the fungi at the taxonomic level.
The sequence analysis of 18S rRNA gene is currently the most
promising approach for the phylogenetic classiﬁcation of
fungi.
In the present study, DNA was isolated for all the bioﬁlm
forming Candida isolates (DV1, DV17, DV21, DV26 and
DV27) and was analyzed in 0.8% agarose. A sharp band
was obtained in the gel. The DNA was found to be approxi-
mately 1300 bp in length (Fig. 3). The 18S rRNA gene ampli-
ﬁcation of the isolates DV1, DV17, DV21, DV26 and DV27
was performed by the PCR technique using 18S rRNA prim-
ers. PCR product was analyzed in 1.2% agarose gel. All theCandida sp. DV17
. DV21
th on catheter by SEM analysis.
Table 5 Determination of the adherence of Candida bioﬁlm
on catheter.
Name of the Candida isolates Optical density (492 nm)
30 min 90 min 180 min
Blank 0.000 0.000 0.000
DV1 0.169 0.281 0.161
DV17 0.148 0.217 0.318
DV21 0.135 0.174 0.150
DV26 0.133 0.166 0.193
DV27 0.031 0.043 0.038
Table 6 Evaluation of bioﬁlm forming time from the bioﬁlm
catheter.
Name of the Candida isolates Optical density (492 nm)
24 h 48 h 72 h
Blank 0.000 0.000 0.000
DV1 1.006 1.469 1.131
DV17 1.116 1.231 1.684
DV21 0.936 1.363 1.340
DV26 0.486 0.963 1.409
DV27 0.728 1.218 1.778
68 D. Dhanasekaran et al.DNA samples except DV26 and DV27 were ampliﬁed. A sharp
band was observed which conﬁrmed the PCR product (Fig. 4).
The nucleotide sequences were obtained from the PCR prod-
ucts. A BLAST similarity search was performed for the ob-
tained nucleotide sequences of the Candida isolates DV1,
DV17 and DV21 and the sequences showed 97%, 96%, 96%
similarity with the C. albicans.
The phylogenetic tree of the Candida isolates DV1, DV17
and DV21 was constructed using its 18S rRNA sequences with
those of the other Candida sp. from the NCBI database. The
resultant phylogenetic tree showed dissimilarity even at the
same species level (Figs. 5–7). The sequences were deposited
in NCBI as C. albicans DV1 (GU056182), C. albicans DV17
(GQ495089) and C. albicans DV21 (GQ495090).
Secondary structure of the 18S rRNA sequence of the Can-
dida isolates DV1, DV17 and DV21 was predicted using the
genebee tool and the structure of DV1 showed 26 loops and
42 stems with an overall free energy of 218.45 kkal/mol
(Fig. 8), Candida sp. DV17 showed 25 loops and 39 stems with
an overall free energy of 184.6 kkal/mol (Fig. 9) and Candida
sp. DV21 showed 27 loops and 43 stems with an overall free
energy of 184.2 kkal/mol (Fig. 10).Table 7 Antibiotic susceptibility of bioﬁlm forming Candida isolat
Name of the Candida isolates Name of the antifungal drug (10 g/m
Amp Nys
DV1 8 5
DV17 6 5
DV21 7 8
Amp – Ampicillin, Nys – Nystatin, Ket – Ketoconazole, Flu – FluconozolThe restriction sites present on the 18S rRNA of Candida
spp. DV1, DV17 and DV21 were analyzed using the NEB cut-
ter program and it showed the site for various commercial and
restriction enzymes. The GC and AT contents of the Candida
isolates DV1, DV17 and DV21 were found to be GC= 49%,
AT= 51%, GC= 48%, AT = 52% and GC= 48%,
AT= 52%, respectively (Figs. 11–13).
3.4. Bioﬁlm formation of Candida sp. on catheter
3.4.1. Microscopic evaluation of Candida bioﬁlms by SEM
Bioﬁlm formation by Candida isolates DV1, DV17 and DV21
on catheter piece were visualized by SEM (Plate 3). Despite its
destructive nature, SEM observations provided useful infor-
mation on the different cellular morphologies present in the
bioﬁlm structure. Initial adherence of yeast cells was followed
by germ tube formation and subsequent development of hy-
phae was seen in Candida isolate DV1 (Plate 3). The formation
of pseudohyphae and blastospores was found in Candida iso-
late DV21 (Plate 3). Mature bioﬁlms consisted of a dense net-
work of cells of all morphologies, deeply embedded in a matrix
consisting of expolymeric material found in the Candida isolate
DV17 (Plate 3), which was better preserved when the bioﬁlm
samples were air dried. SEM image clearly showed the pres-
ence of pseudohyphae, blastospore and EPS production in
the bioﬁlm matrix. Therefore, it was consistent with the forms
observed in C. albicans catheter associated bioﬁlms.2 A similar
study has been reported on bioﬁlm forming Candida in cathe-
ter,7 C. albicans bioﬁlm in the central venous catheter,1 Can-
dida bioﬁlm formation studied using the calgary bioﬁlm
device,14 bioﬁlm formation characters in Candida dublinien-
sis,17 C. albicans,16 Candida bioﬁlms on implanted biomateri-
als,18 yeasts oropharyngeal bioﬁlms on silicone rubber voice
prostheses.20
3.5.1. Optimization of Candida bioﬁlm formation
Basic parameters for bioﬁlm formation such as Candida adhe-
sion, bioﬁlm formation times, total Candida population and
the effect of carbon sources were optimized for the Candida
bioﬁlm formation on the catheter piece (surface area 1 cm2).
Adherence of Candida bioﬁlm to substrate material is a prere-
quisite to the formation of a bioﬁlm. To select the optimal
adhesion time required for bioﬁlm growth, three different time
points (30, 90 and 180 min) were tested. As shown in Table 5,
increasing the adhesion time from 30 to 90 min led to an in-
crease in bioﬁlm growth which was seen in Candida isolates
DV1, DV17, DV21, DV26 and DV27, as determined by
growth determination measurements. Extending the adhesion
phase longer (180 min) resulted in a decrease in bioﬁlm growthes by the disk diffusion method.
l) zone of inhibition (mm in diameter)
Ket Flu Clo Itr
– – – –
– – – –
– – – –
e, Clo – Clotrimazole, Itra – Itraconazole () – No zone of inhibition.
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ﬁndings showed that extending adhesion time from 90 to
180 min resulted in decreased bioﬁlm growth which was similar
to previous studies done by Chandra et al.9
The bioﬁlm formation time was optimized by measuring the
growth of Candida isolates at 492 nm after 24, 48 and 72 h. The
growth rate revealed that the Candida grown as a bioﬁlm in-
creased with gradual increase in time (Table 6). The data indi-
cated that the bioﬁlms produced by the Candida isolates DV17,
DV26 and DV27 were increased when the formation phase was
extended to 72 h.
The total populations of Candida in 1 cm2 area of catheter
were tested in all bioﬁlms forming Candida isolates (DV1,
DV17, DV21, DV26 and DV27). The total number of colonies
that appeared in each plate was counted and calculated. Can-
dida isolate DV1 showed a high range of populations when
compared to the other bioﬁlm forming Candida isolates
(Fig. 1).
In this bioﬁlm model, an adhesion time of 90 min and a bio-
ﬁlm formation time of 72 h were selected as optimal conditions
for growing the Candida spp. Bioﬁlms on catheter material that
were incubated in media supplemented with different sugars
(glucose, sucrose and galactose) were selected. The effect of dif-
ferent sugars on bioﬁlm formation was tested based on earlier
studies that showed that they inﬂuence the adherence capability
ofC. albicans.7 Effect of carbon source on formation ofCandida
bioﬁlmwas screened for all the ﬁve bioﬁlm formingCandida iso-
lates. The results showed that the utilization of sugars by the
Candida isolates was maximum and the growth rate revealed
an increase in bioﬁlm formation. Among the four sugars glucose
showed a higher bioﬁlm formation for all the Candida isolates.
The range of utilization of different sugars was arranged in
ascending order glucose > dextrose > sucrose > galactose
(Fig. 2).3.5.2. Antifungal resistance of bioﬁlm forming Candida spp.
The transition of innocuous commensal Candida to the disease
causing parasitic form can depend on the immune status of the
host especially in immunocompromised patients, suggesting
that Candida bioﬁlms is more resistant to the action of anti-
fungal drugs. In this study, antifungal susceptibility was
screened with both Candida bioﬁlm and non bioﬁlm formers.
The six clinically important antifungal agents viz., Amphoter-
icin B, Ketaconazole, Fluconazole, Itraconazole, Nystatin and
Clotrimazole (10 lg/ml) were screened. The results showed
that, compared with non bioﬁlm formers, bioﬁlm forming
Candida isolates found on the dental surface exhibited resis-
tance to all antifungal drugs (Table 7).
The disk diffusion of bioﬁlm forming Candida isolates resis-
tance to 10 lg for all the six antifungal agents was further
screened for MIC by the agar dilution method. The antibiotics
amphotericin B, ketaconazole, and nystatin were tested at con-
centrations of 16–64 lg/ml. Growth was not observed at con-
centrations of 16–64 lg/ml of all the three antibiotics. The
mechanism contributing to increased antifungal resistance of
bioﬁlm Candida has not yet been deﬁned. Several possibilities
have been investigated, including low growth rate, phenotypic
changes resulting from nutrient limitation and a possible pro-
tective effect of the matrix material. Another possible mecha-
nism that has not yet been explored is the differential
expression of Candidal drug resistance genes (e.g., CDR,MDR) in bioﬁlms. Fungal bioﬁlms role in drug resistance is re-
ported by Jabra et al.9 and antifungal resistance of Candida is
reported by Jain et al.,10 Hawser and Douglas.8
The present study concluded that C. albicans is truly an
opportunistic organism. It is the most frequent cause of candi-
diasis because it is the most successful yeast colonizing the oral
cavity and so is often in a position to take advantage of im-
mune suppression in the host. C. albicans is the most adherent
Candida species, which is probably due to its ability to adhere
to many different ligands. Candida bioﬁlm model will allow us
to investigate this possibility and to characterize the bioﬁlms at
both biochemical and cellular levels. Emerging tools in micros-
copy, genomics and proteomics are likely to elucidate a clearer
picture of the mechanistic and molecular basis behind patho-
genic processes of Candida bioﬁlm formation. Such ﬁndings
might potentially provide us with invaluable clues to combat
the recalcitrant infections caused by this ubiquitous fungus
and also investigate the use of new materials and other preven-
tive strategies that could be employed to inhibit bioﬁlm forma-
tion. A better understanding of Candida bioﬁlms may lead to
the development of novel therapeutic approaches for the treat-
ment for the immunocomprised patients.
Among the 80 dental swabs, 37.50% of them were Candida
and 16.66% of them were bioﬁlm formers. The bioﬁlm screen-
ing assays displayed that three isolates namely DV1, DV17 and
DV21 showed signiﬁcant bioﬁlm forming activity and were
identiﬁed as C. albicans DV1, C. albicans DV17 and C. albi-
cans DV21 based on their morphological, biochemical and
molecular characteristics. The scanning electron microscopic
analysis conﬁrmed the bioﬁlm formations by the Candida iso-
lates on catheter tubes.
The antifungal resistance studies of the Candida isolates
showed that the bioﬁlm forming isolates were signiﬁcantly
resistant to the antifungal drugs in comparison with non-bio-
ﬁlm forming Candida isolates. The present study reveals the
presence of the Candida bioﬁlm on the human dental surface
and indicates the magnitude of antibiotic resistance. The study
has scope for the administration of selection of antifungal
drugs to the dental Candida bioﬁlms and highlights the need
for controlled clinical trials to evaluate the efﬁcacy of potent
treatment strategies. The evaluated drug will prevent the emer-
gence of antifungal resistance of the Candida bioﬁlm.
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